Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease

The overlapping clinical features of relapsing remitting multiple sclerosis (RRMS), aquaporin-4 (AQP4)-antibody (Ab) neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein (MOG)-Ab disease mean that detection of disease specific serum antibodies is the gold standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurynczyk, Maciej, Probert, Fay, Yeo, Tianrong, Tackley, George, Claridge, Tim D. W., Cavey, Ana, Woodhall, Mark R., Arora, Siddharth, Winkler, Torsten, Schiffer, Eric, Vincent, Angela, DeLuca, Gabriele, Sibson, Nicola R., Isabel Leite, M., Waters, Patrick, Anthony, Daniel C., Palace, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718082/
https://www.ncbi.nlm.nih.gov/pubmed/29208041
http://dx.doi.org/10.1186/s40478-017-0495-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718082/
https://www.ncbi.nlm.nih.gov/pubmed/29208041
http://dx.doi.org/10.1186/s40478-017-0495-8

Ejemplares similares